Women with polycystic ovary syndrome often take metformin to help manage their condition. A large review looked at fifty-one clinical trials to see how this drug affects specific hormones in the body. The researchers found that metformin treatment did not change the levels of FSH or LH. These are two hormones that help control the menstrual cycle and egg development. However, the drug did make a clear difference in the ratio between these two hormones. The LH to FSH ratio went up significantly for the women taking the medication. This specific change might be important for fertility or cycle regulation, even if the individual hormone levels stayed the same. The study combined data from many different trials to get a clear picture of what happens across a large group of patients. Safety issues were not reported in the data provided for this review. The findings rely on the results from these fifty-one trials, and the effect size was sensitive to one specific study in the analysis. This means the results could shift if that single trial were excluded. Still, the main takeaway is that metformin has a distinct effect on the balance between these two hormones.
Metformin changes one hormone ratio but leaves others unchanged in PCOS
Photo by DIANA HAUAN / Unsplash
What this means for you:
Metformin increases the LH to FSH ratio but does not change FSH or LH levels in PCOS. More on Polycystic Ovary Syndrome
Meta-analysis finds liraglutide improves menstrual frequency and BMI in overweight women with PCOS A Common Weight Loss Drug May Ease a Hidden Cause of Infertility
· Apr 12, 2026
Paternal metformin use during spermatogenesis shows no increased risk for major congenital malformations in over 11 000 children across five countries New analysis shows fathers taking metformin did not raise birth defect risks for their children
· Jun 1, 2026
Triple oral therapy with metformin, SGLT-2, and DPP-4 inhibitors lowers HbA1c better than dual regimens in adults with type 2 diabetes Triple oral diabetes drugs lower blood sugar better than two-drug regimens
NEJM · May 30, 2026
Lifestyle strategies improve metabolic and hormonal outcomes in PCOS, review finds Lifestyle strategies may help manage polycystic ovary syndrome symptoms in women
Frontiers · May 29, 2026